Blepha EyeBag® | Warming Eye Mask | Relief of Dry, Tired and Sore Eyes | Microwaveable | Previously the MGDRx® EyeBag

Product Information

The NuLids (NuSight Medical, USA) is a home-use device that has a disposable silicone tip that massages the eyelids to remove biofilm and scurf [ 58]. Sarman ZS, Cucen B, Yuksel N, Cengiz A, Caglar Y. Effectiveness of intraductal meibomian gland probing for obstructive meibomian gland dysfunction. Cornea. 2016;35(6):721–4.

Bäumler W, Vural E, Landthaler M, Muzzi F, Shafirstein G. The effects of intense pulsed light (IPL) on blood vessels investigated by mathematical modeling. Lasers Surg Med. 2007;39(2):132–9. VTP improved MG function and symptoms at 6months, but had no effect on MG atrophy; patients with severe MG atrophy responded poorly Greiner JV. Long-term (12-month) improvement in meibomian gland function and reduced dry eye symptoms with a single thermal pulsation treatment. Clin Exp Ophthalmol. 2013;41(6):524–30. The EyeBag should NEVER be exposed to a direct flame. For this reason gas ovens are the least desirable way to heat an EyeBag.Nelson JD, Shimazaki J, Benitez-del-Castillo JM, et al. The International Workshop on Meibomian Gland Dysfunction: report of the definition and classification subcommittee. Investig Ophthalmol Vis Sci. 2011;52(4):1930–7. Stonecipher K, Abell TG, Chotiner B, Chotiner E, Potvin R. Combined low level light therapy and intense pulsed light therapy for the treatment of meibomian gland dysfunction. Clin Ophthalmol. 2019;13:993–9. Eyelid warming therapy associated with eyelid massage has been suggested to induce corneal deformation due to increases in corneal temperature, and with concurrent massaging, possible ectasia. 24 Only one case of corneal deformation following such treatment has been reported, but the duration of treatment in this case was far longer (15 min twice a day for 7 weeks) than that prescribed herein. Transient visual degradation without changes in corneal topography has been observed after warm compresses (45°C) were applied every 2 min for 30 min without massage, 25 but again the duration of treatment and peak temperature was sustained for longer than the present study and the treatment method is not typically advised to MGD patients. Therefore, it appears that corneal deformation and/or visual changes, may only occur following unusually long and intense treatment application durations and long-term therapy associated with eyelid rubbing. For the first 2 weeks use your Blepha EyeBag® twice a day, morning, and evening, for 5 to 10 minutes each time. After the first 2 weeks, 3 to 4 times a week is usual, but you can adjust the frequency of use according to the severity of your symptoms. The MGDRx EyeBag® is a patented, CE marked Class 1 medical device registered with the Medicines and Healthcare products Regulatory Agency (MHRA).

Twenty-five participants completed the study (mean age 38±15 years, 7 male). There was a significant change in OSDI over time for the EyeBag group (mean[lower 95% CI, upper 95% CI], baseline: 39.1[31.1,47.0], 2wk: 26.8[19.7,33.9], 4wk: 26.6[16.5,36.7], 8wk: 27.7[18.4,37.0]; p=0.01), but not in the control group (p=0.22), but no significant difference between groups at all time points (all p>0.27). Symptoms immediately improved after conducting the EyeBag based on at-home CSQ scores (Δ=-5.0 points, p<0.01), but not in the control group. For both groups, there was no significant change (p-value EyeBag,p-value control) in MG score (0.21,0.17) and NIBUT (0.49,0.06) over time. The LipiFlow ® system (Johnson & Johnson Vision, USA) applies heat (42.5 °C) and simultaneous pulsated pressure to the inner upper and lower eyelids for 12 min. The device consists of an eyelid warmer that applies the heat and an eye cup that applies the pressure through an inflatable air bladder [ 35]. Badawi D. TearCare® system extension study: Evaluation of the safety, effectiveness, and durability through 12 months of a second TearCare ® treatment on subjects with dry eye disease. Clin Ophthalmol. 2019;13:189–98. TheBlepha EyeBag (Formally MDG Rx Eyebag ®)is a patented, CE marked Class 1 medical device registered with the Medicines and Healthcare products Regulatory Agency (MHRA). Villani E, Garoli E, Canton V, Pichi F, Nucci P, Ratiglia R. Evaluation of a novel eyelid-warming device in meibomian gland dysfunction unresponsive to traditional warm compress treatment: an in vivo confocal study. Int Ophthalmol. 2015;35(3):319–23.

Hycosan Dual Dry Eye Drops - 7.5ml - Pack of 3

EyeGiene, Bruder Moist Heat Eye Compress, MGDRx EyeBag, TheraPearl mask, rice bag, bundled hot towels, Tranquileyes (Eyeeco), Blephasteam IPL increased the molecular weights of lysozyme, lactoferrin, and albumin as well as the concentrations of total lipids, triglycerides, cholesterol, and phospholipids in tear fluid

Furthermore, a statistically significant improvement in ocular symptoms was also observed in test eyes only. Surprisingly, the improvement in ocular comfort scores was observed as early as the evening of treatment Day 1, suggesting that the eyebag produces an increase in ocular comfort for at least 12h following single use. Although subjects still had raised ocular comfort at around 6months after the trial, comfort was maintained best in those who continued treatment 1–8 times a month. It should be noted that subjects were not masked and, therefore, some placebo effect could be possible, although the effect was marked and occurred in all subjects. Meibomian gland dysfunction (MGD) is a chronic, diffuse abnormality of the meibomian glands (MG), characterized by terminal duct obstruction and changes in the glandular secretion. This anomaly may result in alterations of the tear film, symptoms of eye irritation, clinical inflammation, and ocular surface disease [ 1]. Its prevalence varies between 3.5% and 19.9% in the Caucasian population, while it reaches > 60% in the Asian population [ 2]. The Blepha EyeBag (Formally MDG Rx Eyebag ®) is a patented, CE marked Class 1 medical device registered with the Medicines and Healthcare products Regulatory Agency (MHRA). eyes of 22 MGD patients in each of three groups treated with a hot towel, EyeGiene, or Blephasteam twice daily (67.0±21.7, 57.7±22.7, and 69.7±22.6years, respectively) Dr. Krawitz has served in academia as an Assistant Clinical Professor of Ophthalmology in Manhattan. He has also frequently lectured at professional ophthalmic meetings regarding his highly successful surgical techniques for cataracts, glaucoma and specialty intraocular lenses.This was a prospective, randomized, controlled, observer-masked, bilateral eye study that enrolled 29 participants. Participants were randomized into either the EyeBag group or the control group. The EyeBag group used the EyeBag 10minutes 2x/day, and the control group remained on their own dry eye treatment regimen (if applicable). All participants were observed at baseline, 2 weeks (2wk) and 4 weeks (4wk). At 4wk, participants in the EyeBag group were asked to stop using the EyeBag. All participants were seen again at 8 weeks (8wk). Primary outcomes were the Ocular Surface Disease Index (OSDI), Current Symptoms Questionnaire (CSQ), meibomian gland score (MG score), and non-invasive tear breakup time (NIBUT). Craig JP, Nichols KK, Nichols JJ, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15:276–83. VTP improved MG secretion and reduced symptoms over 1year; early VTP for MGD was associated with improved treatment outcomes DO NOT HEAT IN ANY TYPE OF IMPLEMENT THAT MIGHT CAUSE THE EYEBAG TO BE SET ON FIRE. DO NOT THEREFORE HEAT IN A BARBECUE, GRILL, FONDUE, CHIMINEA, BOILING PAN, CHARGRILL, PANINI MAKER, TOASTER, TOASTED SANDWICH MACHINE, DEEP FAT FRYER, CHIP PAN, OPEN FIRE, COAL EFFECT GAS FIRE, ELECTRIC BAR FIRE, HALOGEN HEATER, SPIT ROAST, BLOW TORCH. THIS LIST IS NOT EXHAUSTIVE. Li D, Bin LS, Cheng B. Intense pulsed light: from the past to the future. Photomed Laser Surg. 2016;34:435–47 (Mary Ann Liebert Inc.).